BioSpace News Archive

MagForce AG successfully completes installation of mobile NanoTherm treatment center for brain tumors in Poland

First hospital outside of Germany to offer MagForce’s NanoTherm therapy for the commercial treatment of brain tumor patients

March 22, 2019
·
6 min read
Adrenomed’s Adrecizumab successfully passes interim analysis in early septic shock study AdrenOSS-II

AdrenOSS-II trial continues as planned after positive interim efficacy analysis triggered by the treatment of 50% of randomized patients

March 22, 2019
·
3 min read
Teva Selects Genedata Biologics to Support Next-generation Biopharmaceuticals R&D

Genedata Biologics® streamlines Teva’s R&D workflows and increases operational efficiency

March 22, 2019
·
4 min read
The Manufacturing and Packaging Awards 2019

GHP Announces the Manufacturing and Packaging Awards 2019 Winners

March 22, 2019
·
1 min read
Drug Development

Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer’s Disease

Independent data monitoring committee advises aducanumab unlikely to meet primary endpoints, leading to decision to discontinue the trials

March 22, 2019
·
4 min read
Biotech Beach

Student uses gene sequencing to understand health benefits of olive oil

While olives might sneak into the American diet occasionally, they are an everyday staple for those living in the Mediterranean basin.

March 22, 2019
·
5 min read
Deals

BioArctic – Statement regarding today’s trading halt

BioArctic AB comments on the decision by Nasdaq Stockholm to halt trading in BioArctic due to large movements in the share price.

March 22, 2019
·
4 min read
Deals

Evotec AG To Report Fiscal Year 2018 Results On 28 March 2019

The Company is going to hold a conference call to discuss the results as well as to provide an update on its performance. Furthermore, the Management Board will present an outlook for fiscal year 2019. The conference call will be held in English.

March 22, 2019
·
3 min read
Lone Star Bio

Alcon to Officially Spin out From Novartis on April 9

Alcon will officially step out from under the Novartis umbrella on April 9 as it will trade on the NYSE and the SIX Swiss Exchange.

March 22, 2019
·
2 min read
·
Alex Keown
Drug Development

Conatus Pharma Stock Craters After 3rd Failed NASH Trial

In an announcement short on details and trying to put a positive spin on things, San Diego-based Conatus Pharmaceuticals indicated its emricasan failed its Phase IIb ENCORE-NF clinical trial in patients with NASH.

March 22, 2019
·
3 min read
·
Mark Terry